Clinical Trial Update: Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Vedolizumab for ulcerative colitis, including its effects on intestinal microecology, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Ulcerative Colitis | Phase 4 | Status: RECRUITING